Search
for
Sort by
Research 30 of 1000+
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
- Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex
- Androgens and Cardiovascular Disease
- Finasteride in the treatment of men with androgenetic alopecia
- Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing
- Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Pharmacology of anabolic steroids
- Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage
- Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Admixture in Latin America: Geographic Structure, Phenotypic Diversity and Self-Perception of Ancestry Based on 7,342 Individuals
- Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors
- Anticancer drugs in surface waters
- Molecular basis of androgen insensitivity
- Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicle
- Polymorphism of the Androgen Receptor Gene is Associated with Male Pattern Baldness